NeuMoDx SARS-Cov-2 Assay Receives FDA EUA
The assay is a real-time RT-PCR diagnostic for covid-19, detecting SARS-CoV-2 coronavirus RNA from nasopharyngeal, oropharyngeal, and nasal swab specimens.
Read MorePosted by | Apr 6, 2020 | Covid 19, Emerging & Zoonotic Diseases, Infectious Diseases |
The assay is a real-time RT-PCR diagnostic for covid-19, detecting SARS-CoV-2 coronavirus RNA from nasopharyngeal, oropharyngeal, and nasal swab specimens.
Read MorePosted by | Apr 2, 2020 | Covid 19, Emerging & Zoonotic Diseases, Infectious Diseases |
A single unit the size of a shoebox can perform 180 amplification runs per day.
Read MorePosted by | Apr 2, 2020 | Covid 19, Emerging & Zoonotic Diseases, Infectious Diseases |
In a single testing run of about 1 hour, the QIAstat Dx test kit can differentiate the SARS-CoV-2 coronavirus from 20 other serious respiratory infections in patients who may have similar symptoms.
Read MorePosted by | Apr 2, 2020 | Covid 19, Emerging & Zoonotic Diseases, Infectious Diseases |
In bench lab tests, the Fluxergy analyzer system, which utilizes PCR and microfluidics technology, has been shown to accurately identify the SARS-CoV-2 virus in less than 1 hour.
Read MorePosted by | Apr 2, 2020 | Covid 19, Emerging & Zoonotic Diseases, Infectious Diseases |
Novacyt’s covid-19 test produces results in less than 2 hours, and can be used on multiple ubiquitous clinical laboratory instrument platforms.
Read More